Trusted Press Release Distribution   Plans | Login    

Briefing Search
Keyword:
Category:

       

    
Author Details
Industry Experts, Inc
media@industry-experts.com
industry-experts.com/

Bookmark and Share
Radiopharmaceuticals Global Market is Projected to Reach $12 billion by 2030
Global Radiopharmaceuticals market is estimated at US$6.8 billion in 2024 and projected to post a CAGR of 10.3% between 2024 and 2030 to reach US$12.2 billion in 2030.

BriefingWire.com, 4/11/2025 - The latest version of the report from Industry Experts Inc, on "Radiopharmaceuticals market," is released. According to this market research report, the global Radiopharmaceuticals market size is estimated at US$6.8 billion in 2024 and projected to post a CAGR of 10.3% between 2024 and 2030 to reach US$12.2 billion in 2030.

The radiopharmaceuticals market is witnessing significant growth, fueled by an increase in the prevalence of cancer and cardiovascular diseases, advancements in imaging technology, and a transition toward personalized medicine. These substances enable accurate diagnoses and targeted treatments, minimizing damage to healthy tissues. Support from government entities, increased investment in research and development, and favorable regulatory approvals are driving innovation and helping resolve supply chain challenges associated with short-lived radioisotopes.

Global Radiopharmaceuticals Market Size

The market for radiopharmaceuticals analyzed in this report globally across all major regions including North America (The United States, Canada, and Mexico), Europe (Germany, France, the United Kingdom, Italy, Spain, and Rest of Europe), Asia-Pacific (Japan, China, India, South Korea, and Rest of Asia-Pacific) and Rest of World.

Radiopharmaceuticals report analyzes the global market trends and outlook with respect to Type – Diagnostic (SPECT Radiopharmaceuticals and PET Radiopharmaceuticals), Therapeutic (Alpha Emitters, Beta Emitters and Brachytherapy Isotopes); Radioisotope – Technetium-99m [Tc-99m], Fluorine-18 [F-18], Lutetium-177 [Lu-177], Iodine-131 [I-131], Gallium-68 [Ga-68], Yttrium-90 [Y-90] and Others [Including Radium-223 {Ra-223}, Rubidium-82, Actinium-225 {Ac-225}, Strontium-89, Copper-64, and more]; Application – Oncology, Cardiology, Neurology and Other Applications [Including Endocrinology, Bone & Skeletal Disorders, Infectious Diseases, Gastrointestinal Disorders, Rheumatologic and Rare Diseases]; and End-Use Facility – Hospitals & Clinics, Medical Imaging Centers, Other End-Users [Including Academic & Research Institutes, Specialty Clinics, Contract Research Organizations {CROs}, and Radiopharmacies].

About Industry Experts, Inc

Industry Experts, Inc., ranks among the leading market research providers globally. The company's off-the-shelf and customized business intelligence reports offer strategic insights and valuable guidance to enable various stakeholders, such as corporate strategists, analysts, researchers and startups, among others, in obtaining valuable, crisp and unbiased current and future market data. For more information, contact us on +1-320-497-3787 or visit [URL=http://industry-experts.com/]Click Here[/URL] https://industry-experts.com/

For the full report: [URL=https://industry-experts.com/verticals/healthcare-and-pharma/global-radiopharmaceuticals-market-products-and-applications]Click Here[/URL] https://industry-experts.com/verticals/healthcare-and-pharma/global-radiopharmaceuticals-market-products-and-applications

 
 
FAQs | Contact Us | Terms & Conditions | Privacy Policy
© 2026 Proserve Technology, Inc.